The European Association of Urology (EAU) has compiled clinical guidelines to provide urologists and oncologists with evidence-based information and recommendations for the management of kidney cancer (renal cell carcinoma, RCC).

It must be emphasised that clinical guidelines present the best evidence available to the experts, but following guideline recommendations will not necessarily result in the best outcome. Guidelines can never replace clinical expertise when making treatment decisions for individual patients. However, they can help to focus decisions taking personal values, preferences, and individual circumstances into account.

Read the full EAU guidelines here. These guidelines were updated in March 2023. Here is a pdf version of the guidelines: EAU Guidelines on RCC 2023

Please note, these guidelines have been written for urologists and oncologists, and the terminology used is not patient-friendly. If you need clarification of these guidelines, please get in touch with us by email. Talk to your doctor or your hospital team about any concerns or issues that you have about the way your kidney cancer is being managed.

Updated: October 2023                                                                                                                      Next review: October 2025